These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 9485357

  • 1. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease.
    Louis JM, Dyda F, Nashed NT, Kimmel AR, Davies DR.
    Biochemistry; 1998 Feb 24; 37(8):2105-10. PubMed ID: 9485357
    [Abstract] [Full Text] [Related]

  • 2. Autoprocessing of HIV-1 protease is tightly coupled to protein folding.
    Louis JM, Clore GM, Gronenborn AM.
    Nat Struct Biol; 1999 Sep 24; 6(9):868-75. PubMed ID: 10467100
    [Abstract] [Full Text] [Related]

  • 3. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
    Paulus C, Ludwig C, Wagner R.
    Virology; 2004 Dec 05; 330(1):271-83. PubMed ID: 15527852
    [Abstract] [Full Text] [Related]

  • 4. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
    Beck ZQ, Hervio L, Dawson PE, Elder JH, Madison EL.
    Virology; 2000 Sep 01; 274(2):391-401. PubMed ID: 10964781
    [Abstract] [Full Text] [Related]

  • 5. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM, Bloom G, Rose SL, Pomeroy SM, O'Brien PO, Perez EE, Sleasman JW, Dunn BM.
    Virology; 2002 Jan 05; 292(1):137-49. PubMed ID: 11878916
    [Abstract] [Full Text] [Related]

  • 6. Dimer disruption and monomer sequestration by alkyl tripeptides are successful strategies for inhibiting wild-type and multidrug-resistant mutated HIV-1 proteases.
    Bannwarth L, Rose T, Dufau L, Vanderesse R, Dumond J, Jamart-Grégoire B, Pannecouque C, De Clercq E, Reboud-Ravaux M.
    Biochemistry; 2009 Jan 20; 48(2):379-87. PubMed ID: 19105629
    [Abstract] [Full Text] [Related]

  • 7. Computational titration analysis of a multiprotic HIV-1 protease-ligand complex.
    Spyrakis F, Fornabaio M, Cozzini P, Mozzarelli A, Abraham DJ, Kellogg GE.
    J Am Chem Soc; 2004 Sep 29; 126(38):11764-5. PubMed ID: 15382890
    [Abstract] [Full Text] [Related]

  • 8. Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.
    Weber IT, Wu J, Adomat J, Harrison RW, Kimmel AR, Wondrak EM, Louis JM.
    Eur J Biochem; 1997 Oct 15; 249(2):523-30. PubMed ID: 9370363
    [Abstract] [Full Text] [Related]

  • 9. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
    Friedler A, Blumenzweig I, Baraz L, Steinitz M, Kotler M, Gilon C.
    J Mol Biol; 1999 Mar 19; 287(1):93-101. PubMed ID: 10074409
    [Abstract] [Full Text] [Related]

  • 10. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
    Song J, Laskowski M, Qasim MA, Markley JL.
    Biochemistry; 2003 Jun 03; 42(21):6380-91. PubMed ID: 12767219
    [Abstract] [Full Text] [Related]

  • 11. Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products.
    Ingallinella P, Altamura S, Bianchi E, Taliani M, Ingenito R, Cortese R, De Francesco R, Steinkühler C, Pessi A.
    Biochemistry; 1998 Jun 23; 37(25):8906-14. PubMed ID: 9636032
    [Abstract] [Full Text] [Related]

  • 12. Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272.
    Wang YX, Freedberg DI, Yamazaki T, Wingfield PT, Stahl SJ, Kaufman JD, Kiso Y, Torchia DA.
    Biochemistry; 1996 Aug 06; 35(31):9945-50. PubMed ID: 8756455
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structural role of the 30's loop in determining the ligand specificity of the human immunodeficiency virus protease.
    Swairjo MA, Towler EM, Debouck C, Abdel-Meguid SS.
    Biochemistry; 1998 Aug 04; 37(31):10928-36. PubMed ID: 9692985
    [Abstract] [Full Text] [Related]

  • 15. Modular total chemical synthesis of a human immunodeficiency virus type 1 protease.
    Johnson EC, Malito E, Shen Y, Rich D, Tang WJ, Kent SB.
    J Am Chem Soc; 2007 Sep 19; 129(37):11480-90. PubMed ID: 17705484
    [Abstract] [Full Text] [Related]

  • 16. Disruption of the HIV-1 protease dimer with interface peptides: structural studies using NMR spectroscopy combined with [2-(13)C]-Trp selective labeling.
    Frutos S, Rodriguez-Mias RA, Madurga S, Collinet B, Reboud-Ravaux M, Ludevid D, Giralt E.
    Biopolymers; 2007 Sep 19; 88(2):164-73. PubMed ID: 17236209
    [Abstract] [Full Text] [Related]

  • 17. The inhibition of HIV-1 protease by interface peptides.
    Schramm HJ, Billich A, Jaeger E, Rücknagel KP, Arnold G, Schramm W.
    Biochem Biophys Res Commun; 1993 Jul 30; 194(2):595-600. PubMed ID: 8343146
    [Abstract] [Full Text] [Related]

  • 18. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB, Lambert DM, Meek TD, Carr TJ, Tomaszek TA, Fernandez AV, Bartus H, Cacciavillani E, Hassell AM, Minnich M.
    Biochemistry; 1992 Jul 28; 31(29):6646-59. PubMed ID: 1637805
    [Abstract] [Full Text] [Related]

  • 19. Lipopeptides as dimerization inhibitors of HIV-1 protease.
    Schramm HJ, de Rosny E, Reboud-Ravaux M, Büttner J, Dick A, Schramm W.
    Biol Chem; 1999 May 28; 380(5):593-6. PubMed ID: 10384967
    [Abstract] [Full Text] [Related]

  • 20. Modification of the substrate specificity of porcine pepsin for the enzymatic production of bovine hide gelatin.
    Galea CA, Dalrymple BP, Kuypers R, Blakeley R.
    Protein Sci; 2000 Oct 28; 9(10):1947-59. PubMed ID: 11106168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.